Reuters logo
9 个月前
BRIEF-Aptevo Therapeutics anticipated experiencing supply interruption of Ixinity 1,500 IU dosage form beginning Dec 2016 - SEC filing
2016年11月28日 / 晚上10点42分 / 9 个月前

BRIEF-Aptevo Therapeutics anticipated experiencing supply interruption of Ixinity 1,500 IU dosage form beginning Dec 2016 - SEC filing

Nov 28 (Reuters) - Aptevo Therapeutics Inc

* Aptevo Therapeutics says on Nov 14, reported co anticipated experiencing supply interruption of Ixinity 1,500 IU dosage form beginning Dec 2016 - SEC filing

* Aptevo Therapeutics says anticipated experiencing supply interruption of Ixinity's all other dosage forms beginning Jan 2017 - SEC filing

* Aptevo Therapeutics says supply interruption relates to challenges associated with manufacture of bulk drug substance (BDS) for ixinity

* Aptevo Therapeutics says continuing to work with BDS supplier to resolve ixinity manufacturing issue Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below